The Future of Aging, AI, and Robotics with CEO of Insilico Medicine
Insilico Medicine’s mission is to extend healthy, productive longevity by transforming drug discovery and development with generative artificial intelligence.
Insilico Medicine’s mission is to extend healthy, productive longevity by transforming drug discovery and development with generative artificial intelligence.
This article looks at how Vibe Bio CEO, Alok Tayi, is seeking to upend drug industry financing.
Endpoint News addressed how parents of children with rare disease are challenging the status quo in drug development.